LOTTE Biologics
Biologics manufacturing services
- B2B
About LOTTE Biologics
A South Korean CDMO company acquired a biologics manufacturing site, offering drug substance production with GMP operational capabilities and global regulatory approvals Expanding with new bio plants
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 251–1,000 employees
- Headquarters
- Seoul, South Korea
- Founded
- 2022
- Revenue
- $49M – $387MTamtam estimate
- Website
- lottebiologics.com
LOTTE Biologics at a glance
LOTTE Biologics is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Seoul, South Korea.
LOTTE Biologics was founded in 2022.
LOTTE Biologics has 251–1,000 employees.
LOTTE Biologics's revenue is $49M – $387M (Tamtam estimate).
Selling to companies like LOTTE Biologics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies